Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease

by Wade T. Iams, MD, Prasad R. Kopparapu, PhD, Yingjun Yan, MS, Anel Muterspaugh, MPH, Zhiguo Zhao, MS, Heidi Chen, PhD, Christopher Cann, MD, Sally York, MD, PhD, Leora Horn, MD, MS, Kristin Ancell, MD, Kenneth Wyman, MD, Caterina Bertucci, MPA, Tristan Shaffer, MS, Lauren A. Hodsdon, MPH, Kavita Garg, PhD, Seyed Ali Hosseini, MD, PhD, Lee P. Lim, PhD, Christine M. Lovly, MD, PhD
Published 2020-06-01

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC

by Jarrod T. Smith, BA, Aneri Balar, MD, Dhairya A. Lakhani, MD, Christien Kluwe, MD, PhD, Zhiguo Zhao, MS, Prasad Kopparapu, PhD, Karinna Almodovar, PhD, Anel Muterspaugh, MPH, CPH, Yingjun Yan, MS, Sally York, MD, PhD, Leora Horn, MD, MSc, Sanja Antic, MS, Caterina Bertucci, MPA, Tristan Shaffer, MS, Lauren Hodsdon, MPH, Kavita Garg, PhD, Seyed Ali Hosseini, MD, PhD, Lee Lim, PhD, Evan Osmundson, MD, PhD, Pierre P. Massion, MD, Christine M. Lovly, MD, PhD, Wade Iams, MD
Published 2021-03-01